title: Proteomic signature of myeloproliferation and neutrophilia: analysis of serum and plasma from healthy subjects given granulocyte colony-stimulating factor.
abstract: OBJECTIVE
  Proteomic analysis could improve our understanding of the mechanisms and consequences of myeloproliferation. Healthy subjects treated with granulocyte colony-stimulating factor (G-CSF) were used as a model of myeloproliferation.
  
  
  METHODS
  Levels of 80 soluble factors were measured by enzyme-linked immunosorbent assay before and after 5 days of G-CSF. Both serum and plasma levels were measured to generate a comprehensive profile and determine whether serum or plasma best portrays biological and physiological changes.
  
  
  RESULTS
  Comparison of samples collected prior to G-CSF demonstrated that 44 factors differed between serum and plasma. Concentrations of several growth factors and chemokines were greater in serum than in plasma, while the opposite was true for several interleukins. Following G-CSF serum levels of 14 factors and plasma levels of 15 factors changed. Eleven increased in both serum and plasma, including cell adhesion molecules (vascular cell adhesion molecule-1, E-selectin, and L-selectin), matrix metalloproteases (MMP-1, -8, and -13), cytokine receptors (tumor necrosis factor receptor 1 and 2, and interleukin-2 receptor), the acute phase reactant, serum amyloid A, and a growth factor, hepatocyte growth factor.
  
  
  CONCLUSIONS
  Some protein levels differ markedly in serum and plasma. Myeloproliferation is associated with changes in the levels of several proteases, adhesion molecules, and cytokines.
authors.affiliation: Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA. dstroncek@cc.nih.gov
authors.forename: David
authors.initials: D
authors.lastname: Stroncek
authors.forename: Stefanie
authors.initials: S
authors.lastname: Slezak
authors.forename: Hanh
authors.initials: H
authors.lastname: Khuu
authors.forename: Christopher
authors.initials: C
authors.lastname: Basil
authors.forename: John
authors.initials: J
authors.lastname: Tisdale
authors.forename: Susan F
authors.initials: SF
authors.lastname: Leitman
authors.forename: Francesco M
authors.initials: FM
authors.lastname: Marincola
authors.forename: Monica C
authors.initials: MC
authors.lastname: Panelli
mesh_terms: D001798:Blood Proteins / Q000032:analysis*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage* / Q000097:blood; D006801:Humans; D007964:Leukocytosis / Q000097:blood* / Q000139:chemically induced; D008297:Male; D011994:Recombinant Proteins
chemical_list: D001798:Blood Proteins; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim